The most beautiful April day in the world,April Jinling,Lush green vegetation,Flowers like brocade! On April 13, 2019, more than 30 blood transfusion industry experts and scholars from all over the country gathered in Jinling, the ancient capital, to participate in the "guidelines for preparation, testing and infusion of leukocyte-depleted mixed concentrated platelets" held at the Nanjing Red Cross Blood Center for review and approval.

The conference was hosted by the Blood Transfusion Equipment and Technology Professional Committee of China Medical Equipment Association, and undertaken by Nanjing Red Cross Blood Center and Nanjing Shuangwei Biomedical Technology Co., Ltd.

The main topic of this meeting is to discuss the draft of the guidelines for preparation, detection and infusion of leukocyte-depleted mixed concentrated platelets, and to determine the draft for review.

The meeting was presided over by Professor Wang Quanli, chairman of the Blood Transfusion Equipment and Technology Professional Committee of the China Medical Equipment Association, and Lu Xiaojun, director of the Nanjing Red Cross Blood Center, delivered a welcome speech. Ms. Hu Zhengfang, Chief Engineer of Shuangwei Biology, summarized nearly 40 expert feedback opinions collected publicly in the past month, and revised the first draft of the draft to be submitted for review according to the expert opinions and submitted it to the participating experts for discussion. Experts from Beijing, Shanghai, Jiangsu, Anhui, Shaanxi, Sichuan, Hunan, Shandong, Guizhou and other places had full and enthusiastic discussions at the meeting. In view of some focal points and hot issues, experts expressed their opinions and spoke freely, carried out in-depth exchanges and full discussions, discussed and revised the first draft for review, and formed a standard draft for review.

Nanjing Shuangwei Biomedical Technology Co., Ltd. is a member unit of the Equipment Association, and is also the unit that proposed the target of this group and the participating unit in the preparation of standards. The company has been committed to the research on the preparation and application of leukocyte-depleted mixed platelet concentrates, and has maintained it for many years. Close clinical communication and continuous improvement of the performance of related products.

Platelet preparations include apheresis platelets and whole blood isolated platelet concentrates. The United Kingdom, Canada and European countries are widely used in whole blood separation and preparation of leukocyte-free mixed concentrated platelets, accounting for more than 50% of platelet component transfusion, so that the valuable platelet resources in whole blood can be effectively utilized.

The smooth convening of this meeting will help our country to standardize the whole process of preparation, quality control and clinical application of leukocyte-depleted concentrated platelets, so that their preparation and use can be regulated, so as to make better use of blood resources and ensure the supply of clinical platelets.